The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus

In vitro and in vivo experimental evidence has contributed important knowledge regarding the antiapoptotic effect mediated by EPO signaling in the damaged brain, particularly through different models with a hypoxic component. However, little emphasis has been placed on the effectiveness of rhEPO adm...

Full description

Bibliographic Details
Main Authors: Martha Catalina Rivera-Cervantes, José Jaime Jarero-Basulto, Justo Murguía-Castillo, Alejandra Guadalupe Marín-López, Yadira Gasca-Martínez, Sergio Cornelio-Martínez, Carlos Beas-Zárate
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.00118/full
_version_ 1819082300733784064
author Martha Catalina Rivera-Cervantes
José Jaime Jarero-Basulto
Justo Murguía-Castillo
Alejandra Guadalupe Marín-López
Yadira Gasca-Martínez
Sergio Cornelio-Martínez
Carlos Beas-Zárate
author_facet Martha Catalina Rivera-Cervantes
José Jaime Jarero-Basulto
Justo Murguía-Castillo
Alejandra Guadalupe Marín-López
Yadira Gasca-Martínez
Sergio Cornelio-Martínez
Carlos Beas-Zárate
author_sort Martha Catalina Rivera-Cervantes
collection DOAJ
description In vitro and in vivo experimental evidence has contributed important knowledge regarding the antiapoptotic effect mediated by EPO signaling in the damaged brain, particularly through different models with a hypoxic component. However, little emphasis has been placed on the effectiveness of rhEPO administration against cellular alterations caused by in vivo excitotoxicity or on the molecular mechanism that regulates this effect. In this study, we investigated the effects of a single dose of rhEPO on hippocampal damage induced by subcutaneous application of monosodium glutamate (MSG) on postnatal days 1, 3, 5 and 7 in neonatal rats. We found that a dose of 1000 IU/kg of b.w. administered 24 h after MSG had the greatest protective effect. In addition, we analyzed changes in gene expression, particularly in 3 key molecules involved in EPO-mediated signaling (EPO, EPOR and βcR). We observed that the expression of EPO and EPOR was differentially modified at both the mRNA and protein levels under the evaluated conditions, while the expression of the βcR gene was substantially increased. Our data suggest that a low dose of rhEPO is sufficient to induce cellular protection under these experimental conditions and that the molecular changes could be a positive feedback mechanism, mediated by reactive astrocytes in association with in vivo neuroprotective mechanisms.
first_indexed 2024-12-21T20:14:29Z
format Article
id doaj.art-4960b91cb1a94f319637f7c2d1cb3cd3
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-21T20:14:29Z
publishDate 2019-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-4960b91cb1a94f319637f7c2d1cb3cd32022-12-21T18:51:40ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-02-011310.3389/fnins.2019.00118437044The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the HippocampusMartha Catalina Rivera-Cervantes0José Jaime Jarero-Basulto1Justo Murguía-Castillo2Alejandra Guadalupe Marín-López3Yadira Gasca-Martínez4Sergio Cornelio-Martínez5Carlos Beas-Zárate6Cellular Neurobiology Laboratory, Department of Cellular and Molecular Biology, CUCBA, University of Guadalajara, Zapopan, MexicoCellular Neurobiology Laboratory, Department of Cellular and Molecular Biology, CUCBA, University of Guadalajara, Zapopan, MexicoCellular Neurobiology Laboratory, Department of Cellular and Molecular Biology, CUCBA, University of Guadalajara, Zapopan, MexicoCellular Neurobiology Laboratory, Department of Cellular and Molecular Biology, CUCBA, University of Guadalajara, Zapopan, MexicoCellular Neurobiology Laboratory, Department of Cellular and Molecular Biology, CUCBA, University of Guadalajara, Zapopan, MexicoRegeneration and Neural Development Laboratory, Department of Cellular and Molecular Biology, CUCBA, University of Guadalajara, Zapopan, MexicoRegeneration and Neural Development Laboratory, Department of Cellular and Molecular Biology, CUCBA, University of Guadalajara, Zapopan, MexicoIn vitro and in vivo experimental evidence has contributed important knowledge regarding the antiapoptotic effect mediated by EPO signaling in the damaged brain, particularly through different models with a hypoxic component. However, little emphasis has been placed on the effectiveness of rhEPO administration against cellular alterations caused by in vivo excitotoxicity or on the molecular mechanism that regulates this effect. In this study, we investigated the effects of a single dose of rhEPO on hippocampal damage induced by subcutaneous application of monosodium glutamate (MSG) on postnatal days 1, 3, 5 and 7 in neonatal rats. We found that a dose of 1000 IU/kg of b.w. administered 24 h after MSG had the greatest protective effect. In addition, we analyzed changes in gene expression, particularly in 3 key molecules involved in EPO-mediated signaling (EPO, EPOR and βcR). We observed that the expression of EPO and EPOR was differentially modified at both the mRNA and protein levels under the evaluated conditions, while the expression of the βcR gene was substantially increased. Our data suggest that a low dose of rhEPO is sufficient to induce cellular protection under these experimental conditions and that the molecular changes could be a positive feedback mechanism, mediated by reactive astrocytes in association with in vivo neuroprotective mechanisms.https://www.frontiersin.org/article/10.3389/fnins.2019.00118/fullmonosodium glutamateerythropoietinerythropoietin receptorbeta common receptorrecombinant human EPOexcitotoxicity
spellingShingle Martha Catalina Rivera-Cervantes
José Jaime Jarero-Basulto
Justo Murguía-Castillo
Alejandra Guadalupe Marín-López
Yadira Gasca-Martínez
Sergio Cornelio-Martínez
Carlos Beas-Zárate
The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus
Frontiers in Neuroscience
monosodium glutamate
erythropoietin
erythropoietin receptor
beta common receptor
recombinant human EPO
excitotoxicity
title The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus
title_full The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus
title_fullStr The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus
title_full_unstemmed The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus
title_short The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus
title_sort recombinant human erythropoietin administered in neonatal rats after excitotoxic damage induces molecular changes in the hippocampus
topic monosodium glutamate
erythropoietin
erythropoietin receptor
beta common receptor
recombinant human EPO
excitotoxicity
url https://www.frontiersin.org/article/10.3389/fnins.2019.00118/full
work_keys_str_mv AT marthacatalinariveracervantes therecombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT josejaimejarerobasulto therecombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT justomurguiacastillo therecombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT alejandraguadalupemarinlopez therecombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT yadiragascamartinez therecombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT sergiocorneliomartinez therecombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT carlosbeaszarate therecombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT marthacatalinariveracervantes recombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT josejaimejarerobasulto recombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT justomurguiacastillo recombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT alejandraguadalupemarinlopez recombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT yadiragascamartinez recombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT sergiocorneliomartinez recombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus
AT carlosbeaszarate recombinanthumanerythropoietinadministeredinneonatalratsafterexcitotoxicdamageinducesmolecularchangesinthehippocampus